Gene: GCNT4
Official Full Name: glucosaminyl (N-acetyl) transferase 4provided by HGNC
Gene Summary: Predicted to enable acetylglucosaminyltransferase activity. Predicted to be involved in O-glycan processing and carbohydrate metabolic process. Predicted to act upstream of or within several processes, including inter-male aggressive behavior; neutrophil homeostasis; and thyroid hormone metabolic process. Predicted to be located in Golgi membrane. [provided by Alliance of Genome Resources, Apr 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA09486 | GCNT4 Knockout cell line (AC16) | Human | GCNT4 | 1:3-1:4 | negative | Online Inquiry |
| KOA24933 | GCNT4 Knockout cell line (BEAS-2B) | Human | GCNT4 | 1:3~1:4 | negative | Online Inquiry |
| KOA40379 | GCNT4 Knockout cell line (U-2932) | Human | GCNT4 | 1:2-1:4 | negative | Online Inquiry |
| KOA55767 | GCNT4 Knockout cell line (TPC-1) | Human | GCNT4 | 1:5-1:8 | negative | Online Inquiry |
| KOA71185 | GCNT4 Knockout cell line (NCM460) | Human | GCNT4 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.